fda approval in breast cancer, review period extended in aml, 2019 aacr highlights, and more
Published 5 years ago • 174 plays • Length 10:00
Download video MP4
Download video MP3
Similar videos
-
7:21
fda approval in breast cancer, breakthrough designations in aml and bladder cancer, and more
-
8:51
fda approvals in nets, breast cancer, aml, a biosimilar, and more
-
10:46
fda approval in all, priority reviews in cml and breast cancer, and more
-
11:00
fda approval in her2 breast cancer, priority review in nsclc, and more
-
11:13
fda approval in her2 early breast cancer, fast track designation in tnbc, and more
-
10:55
fda approval in myeloma, label update in her2 breast cancer, and more
-
9:29
fda approvals in all and breast cancer, priority reviews in cml and follicular lymphoma, and more
-
36:14
mary gloria orji - countering cancer misinformation in nigeria
-
20:59
the blessing and curse of direct oral anticoagulants in the bleeding patient
-
14:05
new fda warning on silicone and saline breast implants: two new cancers (b-cell lymphoma and scc)
-
7:28
fda approvals in pml, nsclc, and breast cancer, priority review in dlbcl, and more
-
6:09
fda approvals in breast cancer and hodgkin lymphoma, 2017 sgo highlights, and more
-
9:35
fda approvals in breast cancer and of a biosimilar, nda submitted in cll, and more
-
7:11
review on 2016 fda approvals, halt on aml trials, and more
-
7:18
full fda approvals in breast cancer and lung cancer, priority reviews in all, and more
-
7:35
fda approval for abemaciclib
-
10:01
fda approvals in sclc and a biosimilar, and japanese approvals in aml, ntrk tumors, and more
-
7:57
fda approvals in breast cancer and melanoma, disappointing results in hnscc, and more
-
10:25
fda approvals in gbm, biosimilar in breast cancer and gastric/gej cancer, and biomarker assay
-
5:38
targeting sort1 positive cancers
-
1:58
recent fda approval of ribociclib as upfront therapy
-
0:53
fda revokes avastin for breast cancer use
Clip.africa.com - Privacy-policy